Viewing Study NCT05997706


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-31 @ 11:06 AM
Study NCT ID: NCT05997706
Status: UNKNOWN
Last Update Posted: 2023-08-18
First Post: 2019-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Unraveling the Klinefelter's Disease Physiopathology
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Organization:

Study Overview

Official Title: Unraveling the Klinefelter's Disease Physiopathology by Organoid Model
Status: UNKNOWN
Status Verified Date: 2023-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: KLINEFELTER
Brief Summary: Organoid Model to unravel Klinefelter Syndrome infertility

Klinefelter Syndrome (KS) is characterized by the presence of an extra chromosome X in male (47,XXY), it is the most frequent genetic cause of azoospermia in adult men. The investigators will isolate and expand spermatogonial cells from KS patients, then using an organoid model investigators will compare the behavior of these Spermatogonia from KS patients when interacting with four combinations of somatic cell types incorporated in the Extra Cellular Matrix hydrogel.
Detailed Description: Men with Klinefelter Syndrome candidate for TESE or microTESE (testicular sperm extraction) for azoospermia.

One extra testicular biopsy (1-2 mm) will be cryopreserved and used later for the cells isolation and culture.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: